Welcome to our dedicated page for Zentek news (Ticker: ZTEK), a resource for investors and traders seeking the latest updates and insights on Zentek stock.
Zentek Ltd. (ZTEK) generates news across several advanced technology domains, reflecting its role as an intellectual property development and commercialization company. Its disclosures highlight activity in graphene-based coatings, critical mineral development, aptamer-based healthcare technologies and fire-retardant materials, giving investors and observers multiple streams of company-specific updates.
A major news theme is Zentek’s work through its wholly owned subsidiary Albany Graphite Corp. on the Albany Graphite Project in Ontario. Recent releases describe ultra-high purity Albany graphite reaching five-nines carbon purity with an Equivalent Boron Concentration below thresholds generally referenced for nuclear applications, as well as additional nuclear suitability testing and independent verification using near-net-shaped graphite bricks. Separate announcements cover lithium-ion battery suitability testing, where spheroidized Albany graphite has shown near-theoretical anode performance under industry-standard conditions.
Another recurring topic is Zentek’s ZenGUARD™ platform for surgical masks and HVAC air filters, including corporate updates on testing under the Government of Canada’s Innovative Solutions Canada program and efforts to advance ZenGUARD™ Enhanced Air Filters in Canada and international markets. News items also address the company’s development of a Graphite Gel-Based Fire-Retardant product and an exclusive licensing arrangement with Altek Advanced Materials Inc. for commercialization in the United States.
Healthcare-focused news includes progress on multivalent aptamer countermeasures against influenza through Triera Biosciences and McMaster University, supported by a federal testing contract. Corporate governance and capital markets developments, such as CEO transitions, board appointments, annual meeting voting results and tax reassessment matters, are reported through regular press releases and associated Form 6-K filings. Readers following ZTEK news can expect updates on technology milestones, regulatory and testing programs, strategic partnerships and key corporate decisions.
Zentek Ltd. (Nasdaq:ZTEK; TSXV:ZEN) announced successful antimicrobial testing for its ZenGUARD™-coated masks conducted by SGS. The testing showed over 99.99% bacterial filtration efficiency after just one hour. Specifically, the mask effectively reduced Escherichia Coli CFU from 260,000 to under 100. Additionally, ZenGUARD™ demonstrated 86.7% antiviral efficiency within one hour against H1N1, increasing to 99.7% after eight hours. These results highlight the potential of ZenGUARD™ to enhance safety for healthcare providers and patients in high-risk environments.
Zentek Ltd. (Nasdaq:ZTEK; TSX-V:ZEN) will have its CEO, Greg Fenton, present at the Industrial Tech Virtual Conference on March 21, 2023, at 2 p.m. ET. Hosted by Maxim Group LLC and available on M-Vest.com, the conference will address emerging technological trends in industrial sectors. Topics include drones, water infrastructure, solar project development, and clean energy technology. Zentek specializes in graphene and nanomaterials for healthcare applications, notably its ZenGUARD™ product, which demonstrates 99% antimicrobial efficacy. For more information, visit Zentek.com.
Zentek Ltd. (Nasdaq: ZTEK), an intellectual property development company, has announced the removal of outdated references to the Albany graphite deposit from its website upon request from the Ontario Securities Commission. This action relates to the 2015 economic analysis that is no longer deemed reliable. The company also revised its corporate presentation to eliminate unsupported statements and potential international partnerships until officially announced. Additionally, Zentek has filed a reciprocal supply agreement with Ekomed Global Inc. on SEDAR, which was due for filing with its Annual Information Form.
Zentek Ltd. (NASDAQ:ZTEK) announced a non-binding letter of intent with 1329307 BC Ltd. on February 13, 2023, to transfer its Albany Graphite Deposit to a new entity, SpinCo, which will be listed on a Canadian stock exchange. Management believes this move will help the project progress towards a prefeasibility study and unlock the asset's value, currently underappreciated in Zentek's share price. The transaction’s final structure will depend on consultations with advisors and requires various approvals. Zentek currently owns 100% of the deposit and aims for the separate entity to advance the project independent of its core operations.
Zentek Ltd. (NASDAQ:ZTEK, TSXV:ZEN) announced the development of ZenARMOR™, a novel corrosion protection technology utilizing functionalized Graphene Oxide. This innovative solution offers improved performance, self-healing properties, and potential environmental benefits due to its low active ingredient content. Third-party testing confirmed excellent corrosion resistance after 1,500 hours in ASTM B-117 tests. Zentek is pre-qualified for the Innovative Solutions Canada testing stream, having filed for a provisional patent and trademark for ZenARMOR™. The company aims to address the significant economic costs of corrosion, estimated at US$452 billion annually in the US.
Zentek Ltd. (Nasdaq:ZTEK), an intellectual property development company, announced the results of Phase 2 testing for its ZenGUARD™ technology in HVAC filtration. The ZenGUARD™ treated MERV 8 filters achieved a 34.56% filtration efficiency against the Phi6 virus, significantly improving from 7.24% in untreated filters. This advancement positions ZenGUARD™ as a potential game-changer for enhancing indoor air quality without incurring high costs for filter upgrades. Zentek is progressing towards commercialization, collaborating with federal organizations and seeking regulatory approvals in North America.
Zentek Ltd. (NASDAQ:ZTEK) has entered a Distribution Agreement with Southmedic Inc. for the distribution of its patented ZenGUARD™ surgical masks in Canada. Southmedic, a leading medical device distributor, aims to introduce ZenGUARD™ masks to hospitals, clinics, and long-term care facilities. This partnership is expected to secure stable demand in the surgical mask market, leveraging Southmedic's established network. Zentek’s ZenGUARD™ technology boasts 99% antimicrobial activity and enhanced filtration efficiency, reinforcing its value proposition in healthcare.
Zentek Ltd. (Nasdaq:ZTEK) announced the appointment of Mitch Swergold as the new Director of Investor Relations. Swergold brings extensive experience in technology investment as a former Senior Analyst and Portfolio Manager. His role will involve enhancing communication with investors and presenting updated business information. Concurrently, Zentek granted him 50,000 stock options at an exercise price of $1.93. The company's innovative products, particularly the antimicrobial ZenGUARD coating, continue to drive its mission in the healthcare sector.
Zentek Ltd. (NASDAQ:ZTEK) announced successful results from Phase 2 HVAC filter testing conducted by the National Research Council of Canada. The ZenGUARD™ coating applied to standard HVAC filters significantly reduced airborne contaminants without affecting airflow rates or energy consumption. This breakthrough could enhance air quality across various sectors, from healthcare to real estate. Zentek plans to further optimize filter configurations and finalize regulatory submissions, moving closer to commercializing ZenGUARD™ products.
Zentek Ltd. (NASDAQ:ZTEK) has been granted Patent Number 3,152,759 by the Canadian Intellectual Property Office for its ZenGUARD™ technology, which includes graphene-silver composites with antimicrobial uses. This patent, valid until September 20, 2041, supports applications in personal protective equipment (PPE) and HVAC systems. CEO Greg Fenton noted the significance of moving from concept to commercialization, emphasizing the importance of intellectual property and the technology's potential to enhance safety and environmental protection.